Allspring Global Investments’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.29M Buy
16,645
+333
+2% +$64.7K 0.01% 949
2025
Q4
$2.83M Buy
16,312
+537
+3% +$97.8K ﹤0.01% 964
2025
Q3
$2.87M Buy
15,775
+5,297
+51% +$940K ﹤0.01% 966
2025
Q2
$1.88M Buy
10,478
+1,362
+15% +$237K ﹤0.01% 1051
2025
Q1
$1.54M Buy
9,116
+117
+1% +$19.2K ﹤0.01% 1150
2024
Q4
$1.36M Buy
8,999
+20
+0.2% +$3.11K ﹤0.01% 1225
2024
Q3
$1.39M Buy
8,979
+2,934
+49% +$438K ﹤0.01% 1250
2024
Q2
$827K Buy
6,045
+222
+4% +$30.4K ﹤0.01% 1379
2024
Q1
$775K Sell
5,823
-149
-2% -$19.3K ﹤0.01% 1427
2023
Q4
$823K Sell
5,972
-189
-3% -$24.8K ﹤0.01% 1386
2023
Q3
$751K Sell
6,161
-23,234
-79% -$3.1M ﹤0.01% 1435
2023
Q2
$4.13M Buy
29,395
+1,421
+5% +$196K 0.01% 1051
2023
Q1
$3.96M Buy
27,974
+20,820
+291% +$2.98M 0.01% 1057
2022
Q4
$1.12M Sell
7,154
-6,052
-46% -$870K ﹤0.01% 1402
2022
Q3
$1.62M Buy
13,206
+518
+4% +$68.2K ﹤0.01% 1300
2022
Q2
$1.69M Sell
12,688
-5,613
-31% -$765K ﹤0.01% 1285
2022
Q1
$2.5M Sell
18,301
-1,319
-7% -$184K ﹤0.01% 1389
2021
Q4
$3.39M Buy
+19,620
New +$2.99M ﹤0.01% 1315

Other funds holding DGX

Allspring Global Investments's DGX Position: Q1 2026 in Review

Allspring Global Investments increased its Quest Diagnostics (DGX) stake by 2% in Q1 2026, buying an estimated $64.7K and bringing the position to 16,645 shares worth $3.29M. The position accounts for 0.01% of the portfolio, ranked #949.

Allspring Global Investments first reported a position in DGX in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.13M in Q2 2023. 1,066 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Allspring Global Investments held 16,645 shares of Quest Diagnostics worth $3.29M as of Q1 2026.
  • Allspring Global Investments bought 333 Quest Diagnostics shares in Q1 2026, an estimated $64.7K.
  • Quest Diagnostics made up 0.01% of Allspring Global Investments's portfolio in Q1 2026, its #949 holding.
  • Allspring Global Investments first reported a position in Quest Diagnostics in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Quest Diagnostics position peaked at $4.13M in Q2 2023.
  • 1,066 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.